We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Help improve GOV.UK Sign up to take part in user research (opens in a new tab)
As football fans across the country get behind England, the MHRA wants to keep any Yellow Cards off the pitch – and instead let people know that Yellow Cards can make an important impact in a very different way by helping ma…
The MHRA is urging people to “summer-proof your health” as warmer weather, travel, and changing routines can affect how medicines and medical devices work, with simple steps to help prevent avoidable harm.
Medicines and Healthcare products Regulatory Agency (MHRA) has approved the use of UK‑donor plasma for five high‑priority plasma-derived medicinal products.
The MHRA’s Criminal Enforcement Unit dismantled a multimillion-pound criminal network responsible for illegally supplying medicines.
As with any medicinal product, the MHRA will keep the safety and effectiveness of nerandomilast under close review.
Merkel cell carcinoma (MCC) is a rare and aggressive type of skin cancer that develops from Merkel cells, specialised neuroendocrine cells found in the top layer of the skin.
The semaglutide injection has been approved to treat metabolic-associated steatohepatitis (MASH) in adults with moderate-to-advanced liver fibrosis.
MHRA CEO argues that for the UK’s long-term health and prosperity, regulation should help lead, rather than follow, innovation
As with any medicinal product, the MHRA will keep the safety and effectiveness of the intravesical delivery system containing gemcitabine under close review.
MHRA investigation secures fraud convictions linked to the supply of non-compliant medical devices.
As with all clinical trials, the MHRA’s top priority is the safety and wellbeing of the trial participants.
The MHRA, Advertising Standards Authority, and the General Pharmaceutical Council have issued a warning to businesses seeking to promote newly authorised medicines, as well as those that do not yet have a marketing authorisa…
MHRA and FDA liaison programme announced to improve regulatory collaboration and support long-standing international partnership.
Dr Nicola Rose, Executive Director of Science and Research at the Medicines and Healthcare products Regulatory Agency (MHRA), has been appointed an OBE in the 2026 King’s Birthday Honours, for services to science and public …
As with any medicine, the MHRA will keep the safety and effectiveness of the adrenaline nasal spray under close review.
Having met the MHRA’s rigorous standards of safety, quality and effectiveness, the semaglutide tablet has been approved in the UK for weight loss and weight management.
The MHRA is publishing the results of an extensive public consultation which will inform the recommendations of the AI Commission and future regulations.
The London sandbox is a secure environment designed to safely test AI-enabled devices in a real-world environment so patients can benefit more quickly.
New AI sandbox will help make medicines safer, speed up development, and reduce reliance on animal testing.
As with all medicines, the MHRA will keep the safety and effectiveness of Nipolcalimab under close review.
Do not include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab and requires JavaScript).